Nature·4 min read·hard
LAMB3 orchestrates EGFR-MAPK-PKM cascade to promote glycolytic reprogramming and progression in laryngeal carcinoma
Z
Zhang, Lu
✦AI Summary
Researchers have identified that the protein LAMB3 promotes the progression of laryngeal carcinoma by activating the EGFR-MAPK-PKM signaling axis. This study suggests that targeting this specific metabolic pathway could offer a new therapeutic strategy for treating the cancer.
Why it matters
Provides a potential new biomarker and therapeutic target for improving the prognosis of patients with laryngeal carcinoma.
Cancer Gene Therapy ( 2026 ) Cite this article
sciencehealth
✦
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in